MTOR and hepatocellular carcinoma: Our group previously reported that suppressed ketone body production resulted from deranged tyrosine catabolism activated mTOR signaling and promoted early hepatic tumorigenesis, indicating an anti-tumor effect of ketone bodies in hepatocellular carcinoma (HCC) [41].